All News

Pharmacists enhance travel medicine by offering tailored consultations, risk assessments, and vaccine management, ensuring safe international travel for patients.

As pharmacists continue to take on greater clinical roles, the growing need to address mental health concerns is reaching a boiling point.

The American Academy of Pediatrics responds to recent HHS vaccine guideline changes with its own schedule for childhood and adolescent patients.

In part 2, Alyssa Billingsley, PharmD, explores some of the recent switches that made waves in the US and how they impact pharmacy operations as well as patient outcomes.

Consultant pharmacists enhance vaccination efforts in long-term care, addressing challenges like vaccine fatigue while advocating for age-friendly care and improved patient outcomes.

With 15 more drugs’ negotiations announced and 1 drug being renegotiated, new prices are set to take effect at the start of 2028.

As respiratory virus season approaches, misinformation threatens lives; understanding vaccines is crucial for protecting our communities and future.

As various regions across the country experience snowstorms, pharmacies must be proactive about ensuring minimal disruptions to their operations.

The Pharmacy Quality Alliance enhances patient outcomes by addressing social determinants of health through effective community partnerships and pharmacist involvement.

GLP-1 therapies gain popularity, but patient adherence struggles due to fragmented support and emotional barriers.

Natalie DiPietro Mager, PharmD, PhD, explores some of the policies that have bolstered maternal health care and what can still be done to further improve patient outcomes.

Amid evolving recommendations for products like acetaminophen as well as influenza vaccines, researchers revisit the role of pharmacists in addressing adolescents’ cold and flu symptoms.

The new provisions would be the first major update to a Medicare Part D statute impacting the pharmacy industry in nearly 20 years.

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

In part 2, ASCP’s senior policy expert James Lewis breaks down the MTF system and how it is impacting the thousands of pharmacies that dispense Medicare-covered drugs.

Medical organizations challenge the government's revised childhood vaccine schedule, urging Congress for immediate oversight and action to protect public health.

Lumateperone shows promising remission rates for major depressive disorder, offering hope for sustained relief in adults when combined with antidepressants.

Pharmacists address the hidden risks of legal substances like nitrous oxide and kratom, emphasizing the need for public education and safety measures.

Fremanezumab significantly reduces migraine days in children and adolescents, offering a vital preventive option for managing episodic migraines.

Gestational diabetes significantly impacts postpartum cardiovascular health, especially in women over 35, highlighting the need for timely interventions.

Focused on lowering costs and saving patients money, the plan is focused on drug prices, insurance premiums, and some of health care’s largest companies.

This marks the disease’s very first treatment option for pediatric patients looking to manage Menkes and its symptoms.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

Educational interventions and pharmacist engagement enhance patient safety in OTC medication use, addressing knowledge gaps and promoting responsible self-care practices.

Mavacamten shows promise in treating adolescent obstructive hypertrophic cardiomyopathy, significantly improving heart function and safety in a pivotal trial.

A group of researchers conducts 3 focus groups centered on community pharmacies in Colorado and Utah and the impact of their closures.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Addressing the lack of evidence regarding pharmacists’ roles as immunization authorities on infant respiratory syncytial virus (RSV) vaccines.